Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
MGK_2's Profile
Displaying 251-300 of 888 result(s).
CYDY CytoDyn Inc
01/14/2024 4:15:19 PM
Warning, this is a long post, but i (9)
CYDY CytoDyn Inc
01/07/2024 9:32:24 PM
here is an answer, but I won't do m (3)
CYDY CytoDyn Inc
01/05/2024 4:49:19 AM
The end of the 12/7/22 R & D Update (7)
CYDY CytoDyn Inc
01/04/2024 8:13:27 AM
I think if the release of HIV from (1)
CYDY CytoDyn Inc
01/04/2024 8:03:54 AM
Being on vacation affords me the ti (7)
CYDY CytoDyn Inc
01/04/2024 4:01:53 AM
do you think these immune activatin
CYDY CytoDyn Inc
01/04/2024 3:57:04 AM
i'm taking the perspective that the (5)
CYDY CytoDyn Inc
01/04/2024 3:45:20 AM
at least from 2020, it was not disc (3)
CYDY CytoDyn Inc
01/03/2024 4:21:02 PM
ohm, I'm putting this out to you, b (3)
CYDY CytoDyn Inc
01/02/2024 1:41:47 PM
Thank you ohm. I appreciate your pe (4)
CYDY CytoDyn Inc
01/01/2024 1:08:24 PM
Happy New Year Longs. I put this to (14)
CYDY CytoDyn Inc
12/13/2023 6:38:33 AM
Thank you so much. This is pertinen (7)
CYDY CytoDyn Inc
12/13/2023 4:50:05 AM
Thank you ohm, your reply is much a (4)
CYDY CytoDyn Inc
12/12/2023 5:59:45 AM
Fascinating Take Cassandra X, Thank (12)
CYDY CytoDyn Inc
12/10/2023 4:24:05 PM
Hope you are successful CGC (2)
CYDY CytoDyn Inc
12/10/2023 4:22:41 PM
Hey biloxiblues, Have you been able (1)
CYDY CytoDyn Inc
12/10/2023 2:30:50 PM
Thanksgiving may count for 2 holida (1)
CYDY CytoDyn Inc
11/24/2023 12:29:09 PM
The 700mg dose achieving 100% recep (2)
CYDY CytoDyn Inc
11/19/2023 4:52:08 PM
Just reaching out here for a shareh (2)
CYDY CytoDyn Inc
11/19/2023 4:46:22 PM
Thank you. Awesome post!
CYDY CytoDyn Inc
11/15/2023 5:16:39 AM
That is interesting ohm. What was i (3)
CYDY CytoDyn Inc
11/14/2023 2:43:10 PM
Leronlimab is broadly acting on the (11)
CYDY CytoDyn Inc
11/12/2023 12:52:39 PM
Ha ha ha, that's all I had to say? (1)
CYDY CytoDyn Inc
11/12/2023 9:12:20 AM
I switched platforms. (4)
CYDY CytoDyn Inc
11/12/2023 6:40:20 AM
Well said. Thank you so much ohm. I (6)
CYDY CytoDyn Inc
11/11/2023 7:13:44 PM
After reading the Interview with th (2)
CYDY CytoDyn Inc
11/11/2023 7:58:33 AM
he would rather not discuss what i
CYDY CytoDyn Inc
11/11/2023 7:09:12 AM
(2)
CYDY CytoDyn Inc
11/03/2023 5:29:19 AM
It was first mentioned in this post (2)
CYDY CytoDyn Inc
11/02/2023 8:59:56 PM
pretty sure it was MD Anderson that (1)
CYDY CytoDyn Inc
10/31/2023 7:07:03 PM
CytoDyn may have kept him on as a c (3)
CYDY CytoDyn Inc
10/31/2023 6:14:21 PM
Personally, I don't believe CA has (3)
CYDY CytoDyn Inc
10/31/2023 8:45:09 AM
Would this have been divulged if CA (3)
CYDY CytoDyn Inc
10/31/2023 7:37:08 AM
When ever there is any thing spoken (4)
CYDY CytoDyn Inc
10/31/2023 4:45:06 AM
If those words took place 10/21/23, (2)
CYDY CytoDyn Inc
10/29/2023 6:36:18 PM
https://www.fda.gov/media/72548/do (4)
CYDY CytoDyn Inc
10/29/2023 3:41:11 PM
we all hear things that a new team (1)
CYDY CytoDyn Inc
10/28/2023 1:01:53 PM
Thank you biloxiblues. Are you assu
CYDY CytoDyn Inc
10/11/2023 4:28:43 AM
(3)
CYDY CytoDyn Inc
10/08/2023 7:32:14 PM
7:35: Before we dive further into t (5)
CYDY CytoDyn Inc
10/01/2023 6:08:55 PM
These findings suggest that blockin (2)
CYDY CytoDyn Inc
10/01/2023 12:08:36 PM
This is (2)
CYDY CytoDyn Inc
09/22/2023 5:13:42 AM
This is what you're re (4)
CYDY CytoDyn Inc
09/18/2023 6:25:39 AM
this is simply an expression of my (2)
CYDY CytoDyn Inc
09/17/2023 9:14:35 PM
you can start thinking that way get (1)
CYDY CytoDyn Inc
09/17/2023 8:01:52 PM
no, not at all Riz, you were not he (1)
CYDY CytoDyn Inc
09/17/2023 5:23:23 PM
From StockTwits Post on Welch , sho (1)
CYDY CytoDyn Inc
09/17/2023 5:13:06 PM
All of the quotes below are taken f (9)
CYDY CytoDyn Inc
08/22/2023 3:58:24 AM
The following link is a must read, (16)
CYDY CytoDyn Inc
08/20/2023 12:20:21 PM
In the recent (4)
Go to page:
  • << First
  • < Previous
  • 5
  • 6
  • Next >

Recent Articles

  • Protecting Your Home From Humidity: Expert Tips & Solutions
  • Lightbridge Advances Nuclear Fuel with New Alloy Fabrication
  • Investigation Launched for Fiserv Shareholders Amid Lawsuit
  • Guardforce AI Showcases Revolutionary AI Solutions in Thailand
  • Soleno Therapeutics Announces Q2 2025 Financial Results Date
  • Home Treatment of Bladder Cancer: UroGen's Research Breakthrough
  • Vertex Report Highlights Increasing Sales Tax Changes Across U.S.
  • Acumen Pharmaceuticals Unveils Promising Developments in Alzheimer's Treatments
  • Important Class Action Filing for Sarepta Therapeutics Investors
  • Legend Biotech Announces Upcoming Q2 2025 Investor Call
  • Market Reactions to US-EU Trade Deal and Performance Insights
  • Legal Action Announced Against Replimune Group Over Securities Fraud
  • NFI Group Strengthens Commuter Coach Leadership with New Order
  • Petco Securities Class Action: Importance of Shareholder Rights
  • NetraMark Partners with AlgoTx to Advance Clinical Trials for Pain Relief
  • Fortrea Holdings Inc. Faces Class Action Due to Investor Claims
  • Great Lakes Dredge & Dock to Announce Q2 2025 Financial Results
  • Legend Biotech's Upcoming Investor Call: Q2 2025 Insights
  • Integral Metals Begins Drilling Program to Explore Critical Minerals
  • Understanding the Securities Class Action Against RxSight, Inc.
  • Hyperion DeFi Expands HYPE Holdings to Enhance Investor Engagement
  • JDE Peet's Updates Share Buyback: What's Next for Investors?
  • Vestis Corporation Faces Class Action Lawsuit Amid Controversies
  • Skyline Bankshares, Inc. Reports Strong Financial Performance
  • Elevating Travel: New Lease Agreement at Ontario Airport
  • Franklin Electric Board Approves Quarterly Dividend of $0.265
  • Bell Canada and Cohere Collaborate for Advanced AI Solutions
  • Enhancing Cybersecurity: Trend Micro and Google Cloud Unite
  • Phathom Pharmaceuticals Announces Upcoming Financial Results Webcast
  • Franklin Electric's Dividend Announcement and Company Insights
  • Transforming Education: Joel Sackett Joins Frontline Education as CPO
  • IMUNON's Stock Dividend Signals Confidence in Growth Strategies
  • Servier Unveils Promising Long-Term Findings in AML Treatment
  • Legal Alert: Stockholders Target Replimune in Class Action Suit
  • Enhancing Alzheimer’s Treatment: NKGen Biotech's Troculeucel Insights
  • Cognizant and Lineage Forge Partnership for Enhanced Experiences
  • Bullish Analyst Ratings Highlight Top Stocks in Technology
  • MARA Holdings Announces Successful $950 Million Note Offering
  • HoldCo Asset Management's Bold Proposal for Comerica's Sale
  • Maris-Tech Receives $144,000 Defense Order for AI Platform
  • Unlocking Monthly Income: Earning $500 from Merck Stock
  • Cumulus Neuroscience Unveils Promising Findings on Alzheimer's Data
  • Brera Holdings Expands Impact in Football with Multi-Club Strategy
  • ATAI Life Sciences and Major Stocks Experience Steep Declines
  • EDENA-BEK Group Unveils Pioneering 24/7 Digital Exchange
  • Urgent Call for Action: Addressing Homeowners Insurance Crisis
  • CreateAI Unveils Animon.ai Studio to Revolutionize Anime Creation
  • 3 E Network Technology Group Explores Bitcoin Investment Strategy
  • KnowBe4 Secures Spot as Leading Email Security Provider
  • CreateAI Revolutionizes Anime Production with Animon.ai Studio
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site